Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Intracerebral Hemorrhage
• Age: Between 18 Year(s) - 120 Year(s)
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Confirmed diagnosis of spontaneous, non-traumatic ICH.
  2. Participants receiving anticoagulants are eligible upon reversal and stability within 24 hours after onset of ICH symptoms.
  3. Able to receive first dose of test article within 24 hours after onset of ICH symptoms.
  4. Controlled blood pressure.
  5. Has adequate venous access.
  6. No planned surgical intervention except EVD.
  7. Written informed consent from the patient or legally authorized representative.

  
  

You may not be eligible for this study if the following are true:

• 1. Unstable hematoma.
  2. Anticipated neurosurgical evacuation by open surgery or minimally invasive surgery with or without Alteplase (EVD allowed).
  3. Uncontrolled temperature.
  4. Signs of intracranial infection or emergence of a systemic infection.
  5. Pregnant or lactating.
  6. Signs of liver and kidney chronic disease.
  7. Non-reversible bleeding diathesis.
  8. Used any chronic immunosuppressants or chronic anti-inflammatory drugs (excluding low-dose aspirin), by any route of administration within the past 7 days.
  9. Anticipated withdrawal of life-sustaining therapies within the first week after admission.
  10. Patient has any contraindication to the planned study assessments.
  11. Patient has a condition that could interfere with the proposed treatment or unacceptably increase the individual's risk by participating in the study.
  12. Thrombolytic-associated ICH or hemorrhagic conversion of an ischemic stroke, along with other causes of secondary ICH.
  13. Concomitant enrollment in another acute interventional study.